Abstract:BACKGROUND: For diabetic patients, who loss islet cell's function, the most fundamental therapy method is pancreatic or islet transplantation, but all these face the problem of insufficient source and the need of taking immunosuppressants in all their life. OBJECTIVE: To make an adequate knowledge of the stem cells which having the strong abilities of differentiation into insulin-producing cells (IPCs) and its use in diabetic substitutive therapy. RETRIEVE STRATEGY: Researcher of this review searched the Pubmed, ISI Web of Knowledge, Blackwell Synergy Database on computer for the pertinent literature in English between January 2000 and December 2006, using the key words of "stem cells, insulin producing cells, diabetes". Simultaneously, China Journal Full-text Database (CJFD) was undertaken to identify pertinent literature published from January 2000 to December 2006 with the same key words in Chinese, and reading some book related to stem cells in Chinese. 111 articles were checked firstly. Inclusive criteria included the related articles containing human/mouse embryonic or adult stem cells induced into IPCs with different methods such as gene modification, sequential inducing factor and so on, while exclusive criteria included the non-randomized trials reviews, Meta analysis and duplication of one study. LITERATURE EVALUATION: Literature source is major in analysis of articles related to human/mouse embryonic or adult stem cells induced into IPCs. Totally 30 articles were selected, in which one was review and the others were clinical or fundamental empirical study. DATA SYNTHESIS: ①Stem cell undoubtedly become the best semen cell of beta cells because of the extreme self-renewal and the multi-directional differentiation potency. ②A large number of reports have now demonstrated that human or mouse embryonic stem cells (ESCs) can be differentiated into cells with an insulin-expressing phenotype, either by genetic manipulation or by permitting spontaneous differentiation followed by culture under selective conditions. ③Obviously, the more directive way obtaining the substitute of beta cell is to expand and induce pancreas stem cell. But using this method in clinic, there may be some work to do, including finding the optimal project for expanding and inducing and the optimal transplantation position. ④Progenitor cells from tissues other than the pancreas have also received considerable attention, such as hepatic stem cells and marrow mesenchymal stem cell. ⑤More newer research set about the directional differentiation of bone marrow-derived stem cells, foetus cord blood, cord mesenchymal stem cell, placenta-derived multipotent cells (PMCs) and so on, in order to explore more cells to use in cell substitutive therapy. CONCLUSION: The research of the directional differentiation of beta cells from embryonic and pancreatic stem cells ignite the hope of the diabetic patients, thought the application of stem cells for diabetes is in the stage of animal experiment. The deeper comprehension with the pancreatic henogenesis mechanisms and the molecule regulation mechanism of differentiation of beta cells from stem cells has, the faster the diabetic cell therapy develops.

Recent progress in differentiation of mesenchymal stem cells into islet-like cells

Research progress in the differentiation of stem cells into islet-producing cells

Advancing diabetes treatment: the role of mesenchymal stem cells in islet transplantation

Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus

Differentiation of multipotent stem cells to insulin-producing cells for treatment of diabetes mellitus: bone marrow- and adipose tissue-derived cells comparison

Research Progress of Mesenchymal Stem Cells in The Treatment of Diabetes Mellitus

The progress of islet cells co-transplantation with bone marrow mesenchymal stem cells in the treatment of diabetes

Comparative Study of Three Types of Mesenchymal Stem Cell to Differentiate into Pancreatic Β-Like Cells in Vitro.

From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Progress and Challenges

Stem cell therapy for diabetes:progress and prospects

Stem cell differentiation and diabetic therapy

Recent progress and prospects of islet stem cells researches

Potential roles of mesenchymal stromal cells in islet allo- and xenotransplantation for type 1 diabetes mellitus

Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in vitro.

The efficiency of stem cell differentiation into functional beta cells for treating insulin-requiring diabetes: Recent advances and current challenges

Current status of stem cell therapy for type 1 diabetes: a critique and a prospective consideration

Bone marrow mesenchymal stem cells promote the repair of islets from diabetic mice through paracrine actions.

The Reversal of Hyperglycaemia in Diabetic Mice Using Plga Scaffolds Seeded with Islet-Like Cells Derived from Human Embryonic Stem Cells

Multipotent Mesenchymal Stromal Cells Interact and Support Islet of Langerhans Viability and Function

An Improved Protocol for Isolating and increasing the Multiple Differentiation Potentials of Mesenchymal Stem Cells from Human Bone Marrow

Microvesicles facilitate the differentiation of mesenchymal stem cells into pancreatic beta-like cells via miR-181a-5p/150-5p